Clinical trial Recruiting at 1 site Interventional Ages 30 to 75

Foot reflexology and ta-VNS for symptom relief in head and neck cancer during CCRT

Official title: Efficacy of Foot Reflexology and Transcutaneous Auricular Vagus Nerve Stimulation on Pain, Xerostomia, Fatigue, Sleep, and Treatment-Related Symptoms in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy: A Randomized, Single-Blind, Sham-Controlled Trial

Run by Tzu Chi University · NCT07711626 · Data updated 2026-11-12

This trial tests whether foot reflexology, transcutaneous auricular vagus nerve stimulation, and auricular acupressure can reduce pain, dry mouth, fatigue, and other symptoms for head and neck cancer patients receiving cisplatin-based chemoradiotherapy.

More Head and Neck Neoplasms trials

Quick facts

Study typeInterventional
Ages30 Years to 75 Years
SexAll
Enrollment180 (estimated)
SponsorTzu Chi University
Academic / other
Locations1 site (Hualien City)
StatusRecruiting
StartedJuly 13, 2026
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedJuly 24, 2026
Trial IDNCT07711626 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 30-75 with pathologically confirmed head and neck cancer (stage II-IVA) scheduled for a second cycle of cisplatin-based CCRT, with ECOG ≤2.

Probably not a fit

Patients with significant comorbidities, implanted electronic devices, or severe immunosuppression may not experience benefit and could have increased risks from interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-blind, sham-controlled study examines three passive or self-administered interventions—foot reflexology, ta-VNS, and auricular acupressure—vs. usual care in people with head and neck cancer undergoing a second cycle of cisplatin-based concurrent chemoradiotherapy. Participants are assigned to foot reflexology, ta-VNS (with true and sham subgroups), or a control group, and are evaluated at baseline, week 1, week 2, and week 4. Interventions involve a 20-minute session twice weekly for two weeks (with a sham touch for controls appropriately blinded), ta-VNS parameters set to tolerable tingling, and self-administered auricular acupressure beads. Outcomes will be analyzed using generalized estimating equations to assess changes over time in pain, xerostomia, fatigue, sleep disturbance, and related symptoms. The study is conducted at Hualien Tzu Chi Hospital with Tzu Chi University as lead sponsor.

Why it matters

Potential benefit: If successful, participants may experience reduced pain, dry mouth, and fatigue during CCRT, potentially improving quality of life and treatment adherence.

How similar studies have gone: Prior studies have explored nonpharmacologic supportive therapies for cancer-related symptoms, but this exact combination during CCRT in head and neck cancer is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pathologically confirmed head and neck cancer, clinical stage II-IVA, age 30-75 years, conscious, able to communicate and comprehend, and able to comply with study procedures
* Scheduled to receive a second cycle of cisplatin-based concurrent chemoradiotherapy
* ECOG performance status ≤2

Exclusion Criteria:

* Severe cognitive impairment or psychiatric illness precluding comprehension or cooperation
* Open wounds or skin lesions of the foot or ear, lower-limb edema, history of deep vein thrombosis, or diabetes with most recent HbA1c \>7.5%
* Cardiac pacemaker or other implanted electronic device, or other severe cardiovascular disease
* Severe bone-marrow suppression (WBC \<2,000/µL or platelets \<50,000/µL)
* Pregnant or breastfeeding women
* History of epilepsy or seizures
* Physically frail condition

Where it's running

  • Hualien Tzu Chi Hospital, Department of Otorhinolaryngology
    Hualien City, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.